0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell and Gene Therapy Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-27N14117
Home | Market Reports | Science| Biological Sciences
Global Cell and Gene Therapy Market Research Report 2023
BUY CHAPTERS

Global Cell and Gene Therapy Market Research Report 2025

Code: QYRE-Auto-27N14117
Report
June 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell and Gene Therapy Market

The global market for Cell and Gene Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases.
North American market for Cell and Gene Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell and Gene Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell and Gene Therapy include Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Organogenesis Holdings Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy.
The Cell and Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell and Gene Therapy Market Report

Report Metric Details
Report Name Cell and Gene Therapy Market
Segment by Type
  • Rare Diseases
  • Oncology
  • Hematology
  • Cardiovascular
  • Ophthalmology
  • Neurology
  • Other Therapeutic Classes
Segment by Application
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutions
  • Contract Research Organizations (CROs)
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Organogenesis Holdings Inc., Pfizer, Inc., RENOVA THERAPEUTICS, Shanghai Sunway Biotech Co., Ltd.,, Sibiono GeneTech Co. Ltd.,, Spark Therapeutics, Inc., Vericel Corporation, ViroMed Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell and Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell and Gene Therapy Market report?

Ans: The main players in the Cell and Gene Therapy Market are Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Organogenesis Holdings Inc., Pfizer, Inc., RENOVA THERAPEUTICS, Shanghai Sunway Biotech Co., Ltd.,, Sibiono GeneTech Co. Ltd.,, Spark Therapeutics, Inc., Vericel Corporation, ViroMed Co., Ltd.

What are the Application segmentation covered in the Cell and Gene Therapy Market report?

Ans: The Applications covered in the Cell and Gene Therapy Market report are Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Contract Research Organizations (CROs), Hospital, Others

What are the Type segmentation covered in the Cell and Gene Therapy Market report?

Ans: The Types covered in the Cell and Gene Therapy Market report are Rare Diseases, Oncology, Hematology, Cardiovascular, Ophthalmology, Neurology, Other Therapeutic Classes

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Rare Diseases
1.2.3 Oncology
1.2.4 Hematology
1.2.5 Cardiovascular
1.2.6 Ophthalmology
1.2.7 Neurology
1.2.8 Other Therapeutic Classes
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Contract Research Organizations (CROs)
1.3.5 Hospital
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy Market Dynamics
2.3.1 Cell and Gene Therapy Industry Trends
2.3.2 Cell and Gene Therapy Market Drivers
2.3.3 Cell and Gene Therapy Market Challenges
2.3.4 Cell and Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Revenue
3.4 Global Cell and Gene Therapy Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy, Product and Application
3.7 Global Key Players of Cell and Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Breakdown Data by Type
4.1 Global Cell and Gene Therapy Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy Breakdown Data by Application
5.1 Global Cell and Gene Therapy Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy Market Size (2020-2031)
6.2 North America Cell and Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Cell and Gene Therapy Introduction
11.1.4 Amgen Inc. Revenue in Cell and Gene Therapy Business (2020-2025)
11.1.5 Amgen Inc. Recent Development
11.2 bluebird bio, Inc.
11.2.1 bluebird bio, Inc. Company Details
11.2.2 bluebird bio, Inc. Business Overview
11.2.3 bluebird bio, Inc. Cell and Gene Therapy Introduction
11.2.4 bluebird bio, Inc. Revenue in Cell and Gene Therapy Business (2020-2025)
11.2.5 bluebird bio, Inc. Recent Development
11.3 Dendreon Pharmaceuticals LLC.
11.3.1 Dendreon Pharmaceuticals LLC. Company Details
11.3.2 Dendreon Pharmaceuticals LLC. Business Overview
11.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Introduction
11.3.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (2020-2025)
11.3.5 Dendreon Pharmaceuticals LLC. Recent Development
11.4 Fibrocell Science, Inc.
11.4.1 Fibrocell Science, Inc. Company Details
11.4.2 Fibrocell Science, Inc. Business Overview
11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Introduction
11.4.4 Fibrocell Science, Inc. Revenue in Cell and Gene Therapy Business (2020-2025)
11.4.5 Fibrocell Science, Inc. Recent Development
11.5 Human Stem Cells Institute
11.5.1 Human Stem Cells Institute Company Details
11.5.2 Human Stem Cells Institute Business Overview
11.5.3 Human Stem Cells Institute Cell and Gene Therapy Introduction
11.5.4 Human Stem Cells Institute Revenue in Cell and Gene Therapy Business (2020-2025)
11.5.5 Human Stem Cells Institute Recent Development
11.6 Kite Pharma, Inc.
11.6.1 Kite Pharma, Inc. Company Details
11.6.2 Kite Pharma, Inc. Business Overview
11.6.3 Kite Pharma, Inc. Cell and Gene Therapy Introduction
11.6.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (2020-2025)
11.6.5 Kite Pharma, Inc. Recent Development
11.7 Kolon TissueGene, Inc.
11.7.1 Kolon TissueGene, Inc. Company Details
11.7.2 Kolon TissueGene, Inc. Business Overview
11.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Introduction
11.7.4 Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (2020-2025)
11.7.5 Kolon TissueGene, Inc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Cell and Gene Therapy Introduction
11.8.4 Novartis AG Revenue in Cell and Gene Therapy Business (2020-2025)
11.8.5 Novartis AG Recent Development
11.9 Orchard Therapeutics plc.
11.9.1 Orchard Therapeutics plc. Company Details
11.9.2 Orchard Therapeutics plc. Business Overview
11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Introduction
11.9.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Business (2020-2025)
11.9.5 Orchard Therapeutics plc. Recent Development
11.10 Organogenesis Holdings Inc.
11.10.1 Organogenesis Holdings Inc. Company Details
11.10.2 Organogenesis Holdings Inc. Business Overview
11.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Introduction
11.10.4 Organogenesis Holdings Inc. Revenue in Cell and Gene Therapy Business (2020-2025)
11.10.5 Organogenesis Holdings Inc. Recent Development
11.11 Pfizer, Inc.
11.11.1 Pfizer, Inc. Company Details
11.11.2 Pfizer, Inc. Business Overview
11.11.3 Pfizer, Inc. Cell and Gene Therapy Introduction
11.11.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Business (2020-2025)
11.11.5 Pfizer, Inc. Recent Development
11.12 RENOVA THERAPEUTICS
11.12.1 RENOVA THERAPEUTICS Company Details
11.12.2 RENOVA THERAPEUTICS Business Overview
11.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Introduction
11.12.4 RENOVA THERAPEUTICS Revenue in Cell and Gene Therapy Business (2020-2025)
11.12.5 RENOVA THERAPEUTICS Recent Development
11.13 Shanghai Sunway Biotech Co., Ltd.,
11.13.1 Shanghai Sunway Biotech Co., Ltd., Company Details
11.13.2 Shanghai Sunway Biotech Co., Ltd., Business Overview
11.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Introduction
11.13.4 Shanghai Sunway Biotech Co., Ltd., Revenue in Cell and Gene Therapy Business (2020-2025)
11.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Development
11.14 Sibiono GeneTech Co. Ltd.,
11.14.1 Sibiono GeneTech Co. Ltd., Company Details
11.14.2 Sibiono GeneTech Co. Ltd., Business Overview
11.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Introduction
11.14.4 Sibiono GeneTech Co. Ltd., Revenue in Cell and Gene Therapy Business (2020-2025)
11.14.5 Sibiono GeneTech Co. Ltd., Recent Development
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Details
11.15.2 Spark Therapeutics, Inc. Business Overview
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Introduction
11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Business (2020-2025)
11.15.5 Spark Therapeutics, Inc. Recent Development
11.16 Vericel Corporation
11.16.1 Vericel Corporation Company Details
11.16.2 Vericel Corporation Business Overview
11.16.3 Vericel Corporation Cell and Gene Therapy Introduction
11.16.4 Vericel Corporation Revenue in Cell and Gene Therapy Business (2020-2025)
11.16.5 Vericel Corporation Recent Development
11.17 ViroMed Co., Ltd.
11.17.1 ViroMed Co., Ltd. Company Details
11.17.2 ViroMed Co., Ltd. Business Overview
11.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Introduction
11.17.4 ViroMed Co., Ltd. Revenue in Cell and Gene Therapy Business (2020-2025)
11.17.5 ViroMed Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell and Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Rare Diseases
 Table 3. Key Players of Oncology
 Table 4. Key Players of Hematology
 Table 5. Key Players of Cardiovascular
 Table 6. Key Players of Ophthalmology
 Table 7. Key Players of Neurology
 Table 8. Key Players of Other Therapeutic Classes
 Table 9. Global Cell and Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Cell and Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Cell and Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Cell and Gene Therapy Market Share by Region (2020-2025)
 Table 13. Global Cell and Gene Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Cell and Gene Therapy Market Share by Region (2026-2031)
 Table 15. Cell and Gene Therapy Market Trends
 Table 16. Cell and Gene Therapy Market Drivers
 Table 17. Cell and Gene Therapy Market Challenges
 Table 18. Cell and Gene Therapy Market Restraints
 Table 19. Global Cell and Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Cell and Gene Therapy Market Share by Players (2020-2025)
 Table 21. Global Top Cell and Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy as of 2024)
 Table 22. Ranking of Global Top Cell and Gene Therapy Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Cell and Gene Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Cell and Gene Therapy, Headquarters and Area Served
 Table 25. Global Key Players of Cell and Gene Therapy, Product and Application
 Table 26. Global Key Players of Cell and Gene Therapy, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Cell and Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Cell and Gene Therapy Revenue Market Share by Type (2020-2025)
 Table 30. Global Cell and Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Cell and Gene Therapy Revenue Market Share by Type (2026-2031)
 Table 32. Global Cell and Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Cell and Gene Therapy Revenue Market Share by Application (2020-2025)
 Table 34. Global Cell and Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Cell and Gene Therapy Revenue Market Share by Application (2026-2031)
 Table 36. North America Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Cell and Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Cell and Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Cell and Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Cell and Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Cell and Gene Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Cell and Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Cell and Gene Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Cell and Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Cell and Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Cell and Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Cell and Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Amgen Inc. Company Details
 Table 52. Amgen Inc. Business Overview
 Table 53. Amgen Inc. Cell and Gene Therapy Product
 Table 54. Amgen Inc. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 55. Amgen Inc. Recent Development
 Table 56. bluebird bio, Inc. Company Details
 Table 57. bluebird bio, Inc. Business Overview
 Table 58. bluebird bio, Inc. Cell and Gene Therapy Product
 Table 59. bluebird bio, Inc. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 60. bluebird bio, Inc. Recent Development
 Table 61. Dendreon Pharmaceuticals LLC. Company Details
 Table 62. Dendreon Pharmaceuticals LLC. Business Overview
 Table 63. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product
 Table 64. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 65. Dendreon Pharmaceuticals LLC. Recent Development
 Table 66. Fibrocell Science, Inc. Company Details
 Table 67. Fibrocell Science, Inc. Business Overview
 Table 68. Fibrocell Science, Inc. Cell and Gene Therapy Product
 Table 69. Fibrocell Science, Inc. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 70. Fibrocell Science, Inc. Recent Development
 Table 71. Human Stem Cells Institute Company Details
 Table 72. Human Stem Cells Institute Business Overview
 Table 73. Human Stem Cells Institute Cell and Gene Therapy Product
 Table 74. Human Stem Cells Institute Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 75. Human Stem Cells Institute Recent Development
 Table 76. Kite Pharma, Inc. Company Details
 Table 77. Kite Pharma, Inc. Business Overview
 Table 78. Kite Pharma, Inc. Cell and Gene Therapy Product
 Table 79. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 80. Kite Pharma, Inc. Recent Development
 Table 81. Kolon TissueGene, Inc. Company Details
 Table 82. Kolon TissueGene, Inc. Business Overview
 Table 83. Kolon TissueGene, Inc. Cell and Gene Therapy Product
 Table 84. Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 85. Kolon TissueGene, Inc. Recent Development
 Table 86. Novartis AG Company Details
 Table 87. Novartis AG Business Overview
 Table 88. Novartis AG Cell and Gene Therapy Product
 Table 89. Novartis AG Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 90. Novartis AG Recent Development
 Table 91. Orchard Therapeutics plc. Company Details
 Table 92. Orchard Therapeutics plc. Business Overview
 Table 93. Orchard Therapeutics plc. Cell and Gene Therapy Product
 Table 94. Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 95. Orchard Therapeutics plc. Recent Development
 Table 96. Organogenesis Holdings Inc. Company Details
 Table 97. Organogenesis Holdings Inc. Business Overview
 Table 98. Organogenesis Holdings Inc. Cell and Gene Therapy Product
 Table 99. Organogenesis Holdings Inc. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 100. Organogenesis Holdings Inc. Recent Development
 Table 101. Pfizer, Inc. Company Details
 Table 102. Pfizer, Inc. Business Overview
 Table 103. Pfizer, Inc. Cell and Gene Therapy Product
 Table 104. Pfizer, Inc. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 105. Pfizer, Inc. Recent Development
 Table 106. RENOVA THERAPEUTICS Company Details
 Table 107. RENOVA THERAPEUTICS Business Overview
 Table 108. RENOVA THERAPEUTICS Cell and Gene Therapy Product
 Table 109. RENOVA THERAPEUTICS Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 110. RENOVA THERAPEUTICS Recent Development
 Table 111. Shanghai Sunway Biotech Co., Ltd., Company Details
 Table 112. Shanghai Sunway Biotech Co., Ltd., Business Overview
 Table 113. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product
 Table 114. Shanghai Sunway Biotech Co., Ltd., Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 115. Shanghai Sunway Biotech Co., Ltd., Recent Development
 Table 116. Sibiono GeneTech Co. Ltd., Company Details
 Table 117. Sibiono GeneTech Co. Ltd., Business Overview
 Table 118. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product
 Table 119. Sibiono GeneTech Co. Ltd., Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 120. Sibiono GeneTech Co. Ltd., Recent Development
 Table 121. Spark Therapeutics, Inc. Company Details
 Table 122. Spark Therapeutics, Inc. Business Overview
 Table 123. Spark Therapeutics, Inc. Cell and Gene Therapy Product
 Table 124. Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 125. Spark Therapeutics, Inc. Recent Development
 Table 126. Vericel Corporation Company Details
 Table 127. Vericel Corporation Business Overview
 Table 128. Vericel Corporation Cell and Gene Therapy Product
 Table 129. Vericel Corporation Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 130. Vericel Corporation Recent Development
 Table 131. ViroMed Co., Ltd. Company Details
 Table 132. ViroMed Co., Ltd. Business Overview
 Table 133. ViroMed Co., Ltd. Cell and Gene Therapy Product
 Table 134. ViroMed Co., Ltd. Revenue in Cell and Gene Therapy Business (2020-2025) & (US$ Million)
 Table 135. ViroMed Co., Ltd. Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Cell and Gene Therapy Picture
 Figure 2. Global Cell and Gene Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell and Gene Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Rare Diseases Features
 Figure 5. Oncology Features
 Figure 6. Hematology Features
 Figure 7. Cardiovascular Features
 Figure 8. Ophthalmology Features
 Figure 9. Neurology Features
 Figure 10. Other Therapeutic Classes Features
 Figure 11. Global Cell and Gene Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Cell and Gene Therapy Market Share by Application: 2024 VS 2031
 Figure 13. Pharmaceutical and Biotechnology Companies Case Studies
 Figure 14. Research and Academic Institutions Case Studies
 Figure 15. Contract Research Organizations (CROs) Case Studies
 Figure 16. Hospital Case Studies
 Figure 17. Others Case Studies
 Figure 18. Cell and Gene Therapy Report Years Considered
 Figure 19. Global Cell and Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Cell and Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Cell and Gene Therapy Market Share by Region: 2024 VS 2031
 Figure 22. Global Cell and Gene Therapy Market Share by Players in 2024
 Figure 23. Global Top Cell and Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Revenue in 2024
 Figure 25. North America Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Cell and Gene Therapy Market Share by Country (2020-2031)
 Figure 27. United States Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Cell and Gene Therapy Market Share by Country (2020-2031)
 Figure 31. Germany Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Cell and Gene Therapy Market Share by Region (2020-2031)
 Figure 39. China Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Cell and Gene Therapy Market Share by Country (2020-2031)
 Figure 47. Mexico Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Cell and Gene Therapy Market Share by Country (2020-2031)
 Figure 51. Turkey Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Cell and Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Amgen Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 55. bluebird bio, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 56. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 57. Fibrocell Science, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 58. Human Stem Cells Institute Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 59. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 60. Kolon TissueGene, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 61. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 62. Orchard Therapeutics plc. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 63. Organogenesis Holdings Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 64. Pfizer, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 65. RENOVA THERAPEUTICS Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 66. Shanghai Sunway Biotech Co., Ltd., Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 67. Sibiono GeneTech Co. Ltd., Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 68. Spark Therapeutics, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 69. Vericel Corporation Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 70. ViroMed Co., Ltd. Revenue Growth Rate in Cell and Gene Therapy Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS